Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cedars-Sinai Medical Center
With
University of Kansas
University of Pittsburgh
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Completed treatment for stage 1-3 breast cancer at least two months but not more than 24 months prior to enrollment.
Having received chemotherapy with or without radiation therapy
Female, Age ≥18 years.
FACT-Cog score less than 59 on the Perceived Cognitive Impairment subscale
Eligible after 2 months of completing all their active cancer treatment with the exception of long-term hormonal treatments or trastuzumab.
Subjective complaint of cognitive concerns at time of enrollment
Must be able to understand and communicate proficiently in English
Ability to understand and the willingness to sign a written informed consent.
Agree to complete study surveys
You may not be if
Patients who have significant personality disorders or unstable psychiatric disorders (including active major depression, substance abuse, psychosis or bipolar disorder) as assessed by the interviewing clinician
Patients with known brain metastases, history of brain metastases or radiation to the brain.
Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction.
Non-English speakers
Receiving treatment for another malignancy other than breast cancer
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
Clareo Health | Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment
